Recent Updates
Recently added Catalysts
IRON

Disc Medicine to Host Disease Webinar with KOLs on Erythropoietic Protoporphyria (EPP)

Key Takeaway: Disc Medicine to Host Disease Webinar with KOLs on Erythropoietic Protoporphyria (EPP)
Price reaction · baseline $21.5 (2023-04-12 close) · hit after-hours · clean, no other IRON news in the window
day 0 close · peak
+3.3%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+45%
120-day peak, hindsight
Typical move
3.9%
average across 7 past catalysts
Cash runway
~48 mo
Minimal dilution risk
Lead asset
DISC-0974
Phase 2 · Inflammatory Bowel Disease (IBD)

Full Press Release Details

Disc Medicine to Host Disease Webinar with KOLs on Erythropoietic Protoporphyria (EPP).
Last updated: Apr 13, 2023